-
Sarepta’s DMD Gene Therapy Improves Muscle Function in 4 Boys, Trial Shows
Sarepta Therapeutics’ microdystrophin gene therapy improved the muscle function of four boys with Duchenne muscular dystrophy enrolled in a Phase 1/2 trial. Read more about this gene therapy.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.